Literature DB >> 20970236

[Flu and other acute respiratory infections in the working population. the impact of influenza A (H1N1) epidemic].

Constanza Albertí1, Ramon Orriols, Rafael Manzanera, Josefina Jardí.   

Abstract

INTRODUCTION: This study aims to asses the impact of influenza and other acute respiratory infectious diseases (ARI) on the Catalan working population between January 2007 and December 2009, including the period of the influenza virus A (H1N1) pandemic in our region.
METHODS: All certified sickness absence episodes (sick-leave) due to influenza and other ARI amongst the working population of Catalonia, Spain, were analyzed from January 2007 to December 2009. Monthly and weekly incidence was calculated, as well as an influenza sick-leave threshold, in order to identify the epidemic season in the working population.
RESULTS: Registered annual sick-leave incidence for influenza-like illnesses (ILI) per 100,000 workers was 1,260.6 in 2007, 915.2 in 2008 and 2,377.2 in 2009. Epidemic curves show monthly peaks in January-February each year, plus a second peak in November 2009 corresponding to the influenza virus A (H1N1) pandemic in our region. In 2009 sick-leave incidence for ILI and other ARI was higher in workers from the Health-Social Services sector than in the other workers (p<0.001).
CONCLUSION: This study contributes to the knowledge on the impact of influenza and other ARI on the general workforce, during a period of time including the outbreak of influenza virus A (H1N1).
Copyright © 2010 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20970236     DOI: 10.1016/j.arbres.2010.09.002

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  1 in total

Review 1.  The economic burden of influenza among adults aged 18 to 64: A systematic literature review.

Authors:  Caroline de Courville; Sarah M Cadarette; Erika Wissinger; Fabián P Alvarez
Journal:  Influenza Other Respir Viruses       Date:  2022-02-05       Impact factor: 4.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.